preloader
Insilicall
Insilicall

AI to Advance. Discover. Innovate. Empower. Mitigate.

About Us

Our Story

InsilicAll is a Latin American biotech company that combines Artificial Intelligence (AI) and Biological Automation to solve drug discovery and drug design challenges in the pharmaceutical industry. 

The company’s SaaS model improves the success rates of bringing innovative drugs to patients faster, at a lower cost, and with greater safety. InsilicAll’s mission is to deliver the best technology with the lowest impact (ESG) and eliminate animal experimentation in its clients’ processes (cruelty-free). The company integrates AI, computation, and biological automation to accelerate the design of new molecules and protein therapeutics.

Who We Are

History and Investment

The company's SaaS model improves the success rates of bringing innovative drugs to patients faster, at a lower cost, and with greater safety. InsilicAll's mission is to deliver the best technology with the lowest impact (ESG) and eliminate animal experimentation in its clients' processes (cruelty-free). The company integrates AI, computation, and biological automation to accelerate the design of new molecules and protein therapeutics.

InsilicAll was founded in 2019 and has since made significant strides in the field of drug discovery. In 2017, the company was awarded second place in the Biostartup Lab program of Biominas Brazil and was also a finalist in InovAtiva Brasil, demonstrating early recognition of its potential.

The company received its first capital investment from BiotechTown in 2019, and subsequently graduated from the institution's Business Development Program. This provided the necessary resources for InsilicAll to develop its minimum viable product (MVP) of a drug discovery platform with three applications.

Being part of the portfolio of companies invested by BiotechTown brought increased visibility and validation, which helped InsilicAll to secure a second investment round in 2021 with Alvarez & Marsal. This investment has enabled the company to continue developing its technology and expand its team.

InsilicAll’s mission is to revolutionize the drug discovery process, with the aim of bringing effective treatments to patients in a more timely and cost-effective manner. The company’s values are centered around innovation, collaboration, and ethical conduct.

Overall, InsilicAll’s achievements speak to its potential as a leader in the biotech industry, and its commitment to making a positive impact on healthcare.

Who We Are

Services and Products

InsilicAll has been providing innovative solutions for almost four years in the fields of chemical safety risk assessment and innovation. The company has built a strong reputation by offering a wide range of services to the pharmaceutical, cosmetics, and agribusiness industries. The main focus is on helping P&D teams to work more efficiently and collaboratively, especially in the preclinical phase, and ensuring compliance with regulatory requirements for active pharmaceutical ingredients and finished products.

The company's approach to chemical safety and risk assessment goes beyond traditional methods. InsilicAll provides expert guidance and support to companies in designing alternative qualification and safety assessment strategies for impurities and degradation products. It also offers assistance in selecting suitable assays and identifying qualified partners. The aim is to help clients to achieve better results while optimizing their costs.

One of InsilicAll’s standout offerings is the Detoxie® platform. This platform leverages big data and AI to accelerate toxicological risk resolution, enabling companies to make informed decisions faster. The platform also includes computational toxicology laboratories that are staffed with highly trained professionals. This ensures that the platform’s outputs are reliable and accurate.

At InsilicAll, we understand that chemical safety and risk assessment is a critical aspect of the pharmaceutical, cosmetics, and agribusiness industries. Our team of experts is dedicated to providing innovative solutions that help our clients to achieve their goals. We work closely with our clients to ensure that our solutions are tailored to their specific needs and that they receive the best possible service. With our cutting-edge technology and highly skilled team, we are committed to delivering the highest quality services to our clients.

How We Work

Technology and Benefits

InsilicAll's exclusive and proprietary national technology is an integrated SaaS platform that allows the use of various programs, resulting in precise and multifocal analyses that accelerate P&D development, guaranteed by the different perspectives explored. The platform is sold in Drug Discovery PaaS licensing plans (Platform as a Service) consisting of several products that can be purchased individually or collectively according to the client's demand or specific projects. By using InsilicAll's services, clients can comply with legislation, save costs compared to conventional tests, and gain significant efficiency gains in time. The platform allows for documentation in an extremely reduced time frame compared to conventional methodologies. With InsilicAll's technology, clients can achieve their research and development goals faster, more cost-effectively, and with greater precision.

Welcome to InsilicAll, a Latin American biotech company that leverages the power of Artificial Intelligence (AI) and Biological Automation to revolutionize drug discovery and design in the pharmaceutical industry.

Our Mission

At InsilicAll, our mission is to make a positive impact on the world by providing cutting-edge technology to our clients while reducing their environmental, social, and governance (ESG) impact. We are committed to helping our clients optimize their time and costs while eliminating or reducing animal experimentation in their processes, and we firmly believe that this can be achieved by leveraging the power of AI and biological automation.
Our goal is to support our clients in accelerating the drug discovery process, bringing innovative treatments to patients faster, and doing so in a more sustainable and ethical way. We understand the importance of creating new solutions to improve human or animal health, but we also believe that it is our responsibility to reduce the impact of our actions on the environment and society.
At InsilicAll, we are passionate about making a difference in the world and we are proud of our commitment to providing the best technology to our clients while minimizing our impact on the planet. We believe that by working together with our clients and partners, we can make a positive contribution to society and the world we live in.

Teams

Awesome Team

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. It is a long established fact that a reader.

As a highly accomplished CEO with extensive experience in the biotech industry. He currently serves as the CEO of InsilicAll, a leading biotech company that specializes in developing cutting-edge products and services for the life sciences sector. Paulo is a trained biotech application scientist who has a deep understanding of the complex scientific principles that underlie the development of new biotech products.

One of Paulo’s key strengths is his ability to stay in touch with scientists both within and outside of his company. He recognizes the importance of clear and rapid communication in the scientific field, and he has implemented a number of strategies to ensure that InsilicAll remains at the forefront of the biotech industry. Through regular communication with his team of scientists, Paulo is able to identify emerging trends and stay ahead of the curve in terms of product development and innovation.

Paulo remains focused on delivering high-quality products and services to his clients. He approaches his work with a no-hype mentality, and he is committed to maintaining the highest levels of professionalism and integrity in all of his business dealings. Paulo’s deep knowledge of the biotech industry, combined with his strong leadership skills, has helped to position InsilicAll as a leading player in the biotech/Pharma space.

About Us

Paulo Palmeira

Founder & CEO

About Us

Rodolpho Braga

Founder & CTO

As a seasoned expert in the field of pharmaceuticals, I have spent over a decade working to find innovative solutions to the challenges faced by the industry. With a doctorate in Medicinal Chemistry and extensive experience in the field, I have gained a deep understanding of the intricacies involved in drug discovery and toxicology.

Throughout my career, I have held various positions that have helped me develop my vision for the future of the industry. I have worked as a senior toxicologist and drug discovery specialist, where I led complex projects that relied on cutting-edge AI systems to make a real impact. My expertise was also sought after by the Drugs for Neglected Diseases initiative (DNDi), where I worked as a computational chemistry scientist on the Lead Optimization Latin America project (LOLA) in 2017, aimed at developing new treatments for neglected diseases.

Driven by my passion to innovate and make a difference in the industry, I founded InsilicAll, the first Latin American Drug Discovery platform that integrates AI and computation to accelerate the design of small molecule and protein therapeutics, while also evaluating toxicological safety for registering new products. As the Founder and CTO of InsilicAll, I have been able to leverage my expertise to drive innovation and create a brighter future for society as a whole.

Under my leadership, InsilicAll has made remarkable progress in drug discovery, producing a number of successful projects that have earned recognition from industry leaders. In fact, our work has been recognized by the Brazilian Pharma & Health (BPH) initiative, which identified InsilicAll as one of the “hidden champions” in a study aimed at increasing the attraction of investments and the internationalization of Brazilian solutions. As we look to the future, I remain committed to driving innovation in the pharmaceutical industry and contributing to the field of drug discovery and toxicology, and I am confident that InsilicAll will continue to make significant contributions in the years to come.

Get In Touch

Get your right solution, contact now with us.

Contact Us